OXiGENE Announces First Quarter 2012 Earnings Conference Call and Webcast
SOUTH SAN FRANCISCO, Calif., May 2, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report first quarter 2012 results on Wednesday, May 9, 2012. A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm EDT (1:30 p.m. PDT).
To listen to a live or an archived version of the audio webcast, please log on to the Company's website, www.oxigene.com . Under the "Investors" tab, select the link to "Events & Presentations."
OXiGENE's earnings conference call can also be heard live by dialing (888) 841-3431 in the United States and Canada, and +1 (678) 809-1060 for international callers, five minutes prior to the beginning of the call. A replay will be available starting at 7:30 p.m. EDT, (4:30 p.m. PDT) on May 9, 2012 and ending at midnight EDT (9:00 p.m. PDT) on May 15, 2012. To access the replay, please dial 855-859-2056 if calling from the United States or Canada, or 404-537-3406 from international locations. Please refer to replay pass code 75600166.
OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer. The Company's major focus is developing vascular disrupting agents that selectively disrupt abnormal blood vessels associated with solid tumor progression. OXiGENE is dedicated to leveraging its intellectual property and therapeutic development expertise to bring life-extending and life-enhancing medicines to patients.
The OXiGENE, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4969
CONTACT: Investor and Media Contact: firstname.lastname@example.org 650-635-7000
Source: OXiGENE, Inc. 2012 GlobeNewswire, Inc.